Editorial

[1]  A. Tricco,et al.  Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update. , 2022, Diving and hyperbaric medicine.

[2]  A. Simonds,et al.  Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline , 2022, European Respiratory Journal.

[3]  P. Cheung,et al.  Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis , 2022, BMJ.

[4]  S. Tanni,et al.  Use of anticoagulants in patients with COVID-19: a living systematic review and meta-analysis , 2022, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[5]  Eric A. Meyerowitz,et al.  Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis , 2022, PLoS medicine.

[6]  A. Tricco,et al.  Guidance for using artificial intelligence for title and abstract screening while conducting knowledge syntheses , 2021, BMC Medical Research Methodology.

[7]  G. Guyatt,et al.  Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis , 2021, BMJ.

[8]  K. Rabe,et al.  Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients , 2021, Infection.

[9]  O. Wichmann,et al.  Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  P. Meybohm,et al.  Vitamin D supplementation for the treatment of COVID-19: a living systematic review. , 2021, The Cochrane database of systematic reviews.

[11]  Lena Schmidt,et al.  Data extraction methods for systematic review (semi)automation: A living systematic review , 2021, F1000Research.

[12]  A. Simonds,et al.  Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline , 2021, European Respiratory Journal.

[13]  Steve McDonald,et al.  Machine learning reduced workload with minimal risk of missing studies: development and evaluation of a randomized controlled trial classifier for Cochrane Reviews , 2020, Journal of clinical epidemiology.

[14]  G. Guyatt,et al.  A living WHO guideline on drugs for covid-19 , 2020, BMJ.

[15]  E. Wood,et al.  Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. , 2020, The Cochrane database of systematic reviews.

[16]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[17]  Sally Green,et al.  Feasibility and acceptability of living systematic reviews: results from a mixed-methods evaluation , 2019, Systematic Reviews.

[18]  Guy Tsafnat,et al.  A question of trust: can we build an evidence base to gain trust in systematic review automation technologies? , 2019, Systematic Reviews.

[19]  Lara A Kahale,et al.  Living systematic reviews: 4. Living guideline recommendations. , 2017, Journal of clinical epidemiology.

[20]  Georgia Salanti,et al.  Living systematic reviews: 3. Statistical methods for updating meta-analyses. , 2017, Journal of clinical epidemiology.

[21]  Elie A Akl,et al.  SERIES: LIVING SYSTEMATIC REVIEWS Living systematic review: 1. Introduction d the why, what, when, and how , 2022 .